After settling down comfortably into my seat on a flight from Chicago to San Francisco, I started browsing through my digital copy of the latest issue of The Economist. Much to my surprise, I saw an article titled, The Usefulness of Managers beginning with the sentence, "Is your manager really necessary?" Bingo!!! My mind went back to so many discussions we keep having about our Indian Pharma industry and the various arguments about line management and their contributions, role clarity, their usefulness and the often-asked question, “Are they really effective?” When the top leadership says, that effective managers are a rare breed with comments such as, “they are the weakest link in our chain”, my mind keeps racing through with the thought as to, “if they are not, who has to be responsible to make them effective?” Having been a line manager and climbing the ladder against odds, I can understand and empathise with both sides of this management world. However, when these doubts and questions keep raising its head often, my curiosity quotient kept raising a question, “Are we in Indian pharma very unique to have such challenges?” A chance meeting I had with a team of Google senior management personnel based in Google’s headquarters in California during this trip gave me an interesting insight on what Google did and what it continues to do. Much to my solace I found that their apprehensions were similar to what we in Indian Pharma face. The differentiating factor was that their "people operations" team (HR) has applied the Google Way (data analytics) to management analysis and developed a manifesto entitled Eight Habits of Highly Effective Google Managers.

Contact Us
Terms of Service
Privacy Statement

Facebook

Twitter

Youtube

Healthcare Trends

The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research

The Data Graveyard: Why India’s Private Hospitals Fail at...

What Leadership is Not! Position, Authority, or Activity

Leadership is not Measured by Position, Authority, or Activity. It...

Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage

To navigate chaos, you first need to know who...

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of...

Mounjaro Upends Semaglutide Gold Rush: IPM May 2026

1. The Eli Lilly & Mounjaro Disruption: A New...

Marketing

The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research

The Data Graveyard: Why India’s Private Hospitals Fail at...

What Leadership is Not! Position, Authority, or Activity

Leadership is not Measured by Position, Authority, or Activity. It...

Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage

To navigate chaos, you first need to know who...

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of...

Mounjaro Upends Semaglutide Gold Rush: IPM May 2026

1. The Eli Lilly & Mounjaro Disruption: A New...

Policies/Sales

The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research

The Data Graveyard: Why India’s Private Hospitals Fail at...

What Leadership is Not! Position, Authority, or Activity

Leadership is not Measured by Position, Authority, or Activity. It...

Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage

To navigate chaos, you first need to know who...

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of...

Mounjaro Upends Semaglutide Gold Rush: IPM May 2026

1. The Eli Lilly & Mounjaro Disruption: A New...

Strategy

The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research

The Data Graveyard: Why India’s Private Hospitals Fail at...

What Leadership is Not! Position, Authority, or Activity

Leadership is not Measured by Position, Authority, or Activity. It...

Navigating the Jungle: How to Turn Field Chaos Into Your Brand’s Competitive Advantage

To navigate chaos, you first need to know who...

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of...

Mounjaro Upends Semaglutide Gold Rush: IPM May 2026

1. The Eli Lilly & Mounjaro Disruption: A New...

Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
- FFE+CEO RT
- BrandStorm
Solutions & Pricing
Partner

Hot topics

AI and the Future of Pharma Field Sales: Boon or Bane?

India’s pharmaceutical industry runs on the strength of its...

Indian Pharma: The Marketing – Field Disconnect and Its Remedy

The Anomaly Unless you learn to accept that chaos is...

ZS Bets Big on India as Pharma GCCs Rewrite the Global Life Sciences Playbook

With its latest expansion, ZS is placing a decisive...

Boehringer Ingelheim India focuses on partnerships in NCD management

Addressing the media at a roundtable this morning, Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five multinational pharmaceutical companies in India over the next few years. We have been enabling access to our innovator products to patients across India and the neighbouring markets in the diabetes, cardiovascular, stroke and respiratory diseases segments. Our plan in these therapy areas is to build sustainable partnerships to ensure an ecosystem of access and care for patients. We have initiated action in that direction.”